European School of Oncology Task Force Report. New approaches in cancer pharmacology: drug design and development (Part 2).
Workman
P
P
CRC Beatson Laboratories, CRC Department of Medical Oncology, University of Glasgow, U.K.
D'Incalci
M
M
Bursch
W
W
Harrap
K R
KR
Hawkins
R E
RE
Neidle
S
S
Powis
G
G
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D004247:DNA / Q000187:drug effects; D015195:Drug Design; D006801:Humans; D009944:Organoplatinum Compounds / Q000494:pharmacology; D015202:Protein Engineering; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D015398:Signal Transduction / Q000187:drug effects
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D004247:DNA; D011505:Protein-Tyrosine Kinases